Aequs Board Approves ₹650 Crore Promoter-Backed Equity Infusion to Fund Aerospace, Consumer Expansion
Aequs Limited has announced a proposed ₹650 crore equity infusion through warrants by its promoter group, with 50% of the issue amount payable upfront. The company said the funds will be used to support capacity expansion across its aerospace and consumer businesses and strengthen the equity base for its planned borrowing programme.
The announcement was made by Aequs in a stock-exchange filing dated September 25, 2026.
Aequs ₹650 Crore Warrant Issue: Key Details
The Board of Directors has approved the preferential issue of up to 2,80,71,690 warrants, with each warrant convertible into one fully paid-up equity share of face value ₹10.
The warrants will be issued to Mellwood Trustee Services Private Limited, trustee of the Melligeri Private Family Foundation, which is part of the promoter group.
The proposed issue is subject to approval from shareholders and other applicable statutory and regulatory authorities.
Key points of the proposed issue
- Issue size: Approximately ₹650 crore
- Number of warrants: Up to 2.81 crore
- Issue price: ₹231.55 per warrant
- Upfront payment: ₹325 crore, or 50% of the issue size
- Balance payment: Payable upon exercise of the warrants
- Warrant exercise period: Within 18 months from allotment
- Conversion deadline: On or before December 31, 2027
- Proposed subscriber: Mellwood Trustee Services Private Limited, trustee of Melligeri Private Family Foundation
- Shareholder approval: Required
Aequs said the ₹231.55 issue price represents the floor price determined under the applicable SEBI pricing formula.
Promoter Holding to Rise to 60.73%
Following full conversion of the warrants, the combined shareholding of the promoter and promoter group in Aequs is expected to increase from 59.09% to 60.73%.
Aequs also said the promoter has undertaken to pay the balance consideration in full, irrespective of the company’s market price at the time of exercise.
The company said it has received an investment commitment letter dated September 25, 2026, from the promoter in this regard.
Where Will Aequs Use the ₹650 Crore?
According to the company, the proposed equity infusion will primarily support its expansion plans across the aerospace and consumer businesses.
The proceeds are expected to be used for:
- Capacity expansion in aerospace and consumer businesses
- Development of the Hosur facility
- Investments in subsidiaries and joint ventures supporting expansion
- General corporate purposes
- Creating an equity base to support additional term borrowings
Aequs said its current equity requirement through FY28 has been assessed by the Board and the company intends to meet this requirement through the proposed issue.
The company added that a broader capital raise may be considered in the future depending on its growth plans.
Aequs Says Programme Wins Are Driving Capacity Investment
Aequs Executive Chairman & CEO Aravind Melligeri said the company has been winning programmes faster than initially planned, creating a need to invest in capacity ahead of the revenue generated by those programmes.
The promoter-backed issue is therefore intended to provide committed capital for capacity creation while also strengthening the company’s equity base to support associated borrowings.
The promoter group is subscribing at the price determined under the SEBI pricing formula and will pay 50% upfront.
Aerospace Business Remains a Major Growth Area
Aequs operates an integrated manufacturing ecosystem covering capabilities such as forging, precision machining, surface treatment and assembly.
The company said its aerospace business has a portfolio of approximately 5,740 qualified parts covering engine systems, structures, actuation systems, landing systems and assemblies.
Aequs is a Tier-1 supplier to global aerospace companies and system integrators including Airbus, Boeing, Safran and Collins Aerospace, according to the company’s disclosure.
The company also has manufacturing operations serving consumer-related sectors including consumer electronics, plastics, toys and consumer durables.
Hosur Facility and Capacity Expansion in Focus
The proposed funding comes as Aequs works on multiple capacity-expansion opportunities.
The company specifically identified development of its Hosur facility as one of the areas where the proceeds will be deployed.
Aequs said the new equity will also provide the base against which it can raise term borrowings for expansion.
This means the ₹650 crore equity infusion is not only a funding source by itself but is also intended to support the company’s broader debt-funded expansion programme.
Shareholder Approval on October 22
Aequs has scheduled an Extraordinary General Meeting (EGM) on October 22, 2026, through video conferencing to seek shareholder approval for the proposed preferential issue.
The detailed terms and conditions of the issue will be made available to shareholders and filed with the stock exchanges in accordance with applicable regulations.
What This Means for Aequs
The proposed transaction represents a significant capital commitment from the promoter group at a time when Aequs is investing ahead of expected growth.
The immediate focus will be on whether the proposed capital translates into additional manufacturing capacity, programme wins and revenue growth across the company’s aerospace and consumer businesses.
At the same time, investors will need to track the eventual warrant conversion, the company’s borrowing requirements and the execution of its planned capacity expansion.
The proposed issue is subject to shareholder and regulatory approvals, and the company’s future performance will depend on the execution of its expansion plans and the demand generated by its customer programmes.
Source: Aequs Limited stock-exchange filing and company press release dated September 25, 2026.
Disclaimer: This article is for informational purposes only and should not be considered investment advice. Investors should review the company’s official filings and assess the risks before making any investment decision.
